These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 31642637)

  • 1. Dalbavancin for treating prosthetic joint infections caused by Gram-positive bacteria: A proposal for a low dose strategy. A retrospective cohort study.
    Buzón Martín L; Mora Fernández M; Perales Ruiz JM; Ortega Lafont M; Álvarez Paredes L; Morán Rodríguez MA; Fernández Regueras M; Machín Morón MA; Mejías Lobón G
    Rev Esp Quimioter; 2019 Dec; 32(6):532-538. PubMed ID: 31642637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter clinical experience of real life Dalbavancin use in gram-positive infections.
    Wunsch S; Krause R; Valentin T; Prattes J; Janata O; Lenger A; Bellmann-Weiler R; Weiss G; Zollner-Schwetz I
    Int J Infect Dis; 2019 Apr; 81():210-214. PubMed ID: 30794940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dalbavancin in the treatment of different gram-positive infections: a real-life experience.
    Bouza E; Valerio M; Soriano A; Morata L; Carus EG; Rodríguez-González C; Hidalgo-Tenorio MC; Plata A; Muñoz P; Vena A;
    Int J Antimicrob Agents; 2018 Apr; 51(4):571-577. PubMed ID: 29180276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dalbavancin Efficacy and Impact on Hospital Length-of-Stay and Treatment Costs in Different Gram-Positive Bacterial Infections.
    Poliseno M; Bavaro DF; Brindicci G; Luzzi G; Carretta DM; Spinarelli A; Messina R; Miolla MP; Achille TI; Dibartolomeo MR; Dell'Aera M; Saracino A; Angarano G; Favale S; D'Agostino C; Moretti B; Signorelli F; Taglietti C; Carbonara S
    Clin Drug Investig; 2021 May; 41(5):437-448. PubMed ID: 33884583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dalbavancin in Gram-positive periprosthetic joint infections.
    Simon S; Frank BJH; Hartmann S; Hinterhuber L; Reitsamer M; Aichmair A; Dominkus M; Söderquist B; Hofstaetter JG
    J Antimicrob Chemother; 2022 Jul; 77(8):2274-2277. PubMed ID: 35678452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world experience with dalbavancin therapy in gram-positive skin and soft tissue infection, bone and joint infection.
    Tobudic S; Forstner C; Burgmann H; Lagler H; Steininger C; Traby L; Vossen MG; Winkler S; Thalhammer F
    Infection; 2019 Dec; 47(6):1013-1020. PubMed ID: 31520397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periprosthetic Joint Infections Caused by Enterococci Have Poor Outcomes.
    Kheir MM; Tan TL; Higuera C; George J; Della Valle CJ; Shen M; Parvizi J
    J Arthroplasty; 2017 Mar; 32(3):933-947. PubMed ID: 27789094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections.
    Veve MP; Patel N; Smith ZA; Yeager SD; Wright LR; Shorman MA
    Int J Antimicrob Agents; 2020 Dec; 56(6):106210. PubMed ID: 33223119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of prosthetic joint infections due to Propionibacterium. Similar results in 60 patients treated with and without rifampicin.
    Jacobs AM; Van Hooff ML; Meis JF; Vos F; Goosen JH
    Acta Orthop; 2016 Feb; 87(1):60-6. PubMed ID: 26414972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying Common Pathogens in Periprosthetic Joint Infection and Testing Drug-resistance Rate for Different Antibiotics: A Prospective, Single Center Study in Beijing.
    Li ZL; Hou YF; Zhang BQ; Chen YF; Wang Q; Wang K; Chen ZY; Li XW; Lin JH
    Orthop Surg; 2018 Aug; 10(3):235-240. PubMed ID: 30152610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current trends in the real-life use of dalbavancin: report of a study panel.
    Durante-Mangoni E; Gambardella M; Iula VD; De Stefano GF; Corrado MF; Esposito V; Gentile I; Coppola N
    Int J Antimicrob Agents; 2020 Oct; 56(4):106107. PubMed ID: 32721599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid in the treatment of Gram-positive prosthetic joint infections.
    Bassetti M; Vitale F; Melica G; Righi E; Di Biagio A; Molfetta L; Pipino F; Cruciani M; Bassetti D
    J Antimicrob Chemother; 2005 Mar; 55(3):387-90. PubMed ID: 15705640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The unsuspected prosthetic joint infection : incidence and consequences of positive intra-operative cultures in presumed aseptic knee and hip revisions.
    Jacobs AME; Bénard M; Meis JF; van Hellemondt G; Goosen JHM
    Bone Joint J; 2017 Nov; 99-B(11):1482-1489. PubMed ID: 29092987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dalbavancin treatment for prosthetic joint infections in real-life: a national cohort study and literature review.
    Matt M; Duran C; Courjon J; Lotte R; Moing VL; Monnin B; Pavese P; Chavanet P; Khatchatourian L; Tattevin P; Cattoir V; Lechiche C; Illes G; Lacassin-Beller F; Senneville E; Dinh A;
    J Glob Antimicrob Resist; 2021 Jun; 25():341-345. PubMed ID: 33962065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Therapy, Microbiological Findings, and Comorbidity Influence the Outcome of Prosthetic Joint Infections Undergoing 2-Stage Exchange.
    Ascione T; Pagliano P; Balato G; Mariconda M; Rotondo R; Esposito S
    J Arthroplasty; 2017 Jul; 32(7):2239-2243. PubMed ID: 28372916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dalbavancin treatment of prosthetic knee infection due to oxacillin-resistant Staphylococcus epidermidis.
    Ramírez Hidalgo M; Jover-Sáenz A; García-González M; Barcenilla-Gaite F
    Enferm Infecc Microbiol Clin (Engl Ed); 2018 Feb; 36(2):142-143. PubMed ID: 28600171
    [No Abstract]   [Full Text] [Related]  

  • 17. [ANTIBIOTIC-IMPREGNATED ARTICULAR CEMENT SPACER FOR TREATMENT OF PERIPROSTHETIC JOINT INFECTION].
    Zhang W; Li W; Bai G; Huang Z; Wu H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2015 Apr; 29(4):420-5. PubMed ID: 26477151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative joint aspiration culture results and causative pathogens in total hip and knee prosthesis infections: mind the gap.
    Declercq P; Neyt J; Depypere M; Goris S; Van Wijngaerden E; Verhaegen J; Wauters J; Spriet I
    Acta Clin Belg; 2020 Aug; 75(4):284-292. PubMed ID: 31057053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of clinical evidence for dalbavancin].
    Rodríguez-Pardo D
    Enferm Infecc Microbiol Clin; 2017 Jan; 35 Suppl 1():33-37. PubMed ID: 28129819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility.
    Almangour TA; Perry GK; Terriff CM; Alhifany AA; Kaye KS
    Diagn Microbiol Infect Dis; 2019 Mar; 93(3):213-218. PubMed ID: 30396697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.